Pfizer Inc. PFE
Set alert
30.49 USD -0.18 -0.59%
As of Nov 3, 1:39 PM ET
30.25 Day range 31.05
23.67 52-week range 30.67
- YTD
- +22.45%
- 1 year
- +23.64%
- Open
- 30.68
- Prev close
- 30.67
- Mkt cap
- 173.70B
- Vol
- 25.16M
- Avg vol
- 33.91M
- EPS
- 0.76
- P/E
- 40.10
- Div yield
- 5.74%
More statistics
- Low
- 30.25
- High
- 31.05
- Forward P/E
- 10.64
- Beta
- 0.30
- Short ratio
- 4.20
- Inst. own
- 69.11%
- Dividend
- 1.72
- Ex-div date
- Nov 5, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 28.55
- 200-d avg
- 26.80
- 1y target
- 29.26
5Y chart
Events in this range
- Nov 4, 2021Dividend: 0.39
- Jan 27, 2022Dividend: 0.4
- May 12, 2022Dividend: 0.4
- Jul 28, 2022Dividend: 0.4
- Nov 3, 2022Dividend: 0.4
- Dec 5, 2022Dividend: 0.4
- Jan 26, 2023Dividend: 0.41
- May 11, 2023Dividend: 0.41
- Jul 27, 2023Dividend: 0.41
- Nov 9, 2023Dividend: 0.41
- Nov 10, 2023Dividend: 0.41
- Jan 25, 2024Dividend: 0.42
- Jan 26, 2024Dividend: 0.42
- May 9, 2024Dividend: 0.42
- Jul 25, 2024Dividend: 0.42
- Jul 26, 2024Dividend: 0.42
- Nov 8, 2024Dividend: 0.42
- Jan 24, 2025Dividend: 0.43
- May 9, 2025Dividend: 0.43
- Jul 25, 2025Dividend: 0.43
- Aug 5, 2025Earnings: 0.78; estimate 0.58; surprise 34.48%
- Nov 4, 2025Earnings: 0.87; estimate 0.633; surprise 37.44%
- Nov 7, 2025Dividend: 0.43
- Jan 23, 2026Dividend: 0.43
- Feb 3, 2026Earnings: 0.66; estimate 0.567; surprise 16.4%
- May 5, 2026Earnings: 0.75; estimate 0.722; surprise 3.88%
- May 8, 2026Dividend: 0.43
- Jul 13, 2026Rating: BMO Capital · Outperform → Outperform
- Jul 24, 2026Dividend: 0.43
- Aug 4, 2026Earnings: 0.77; estimate 0.682; surprise 12.9%
- Aug 7, 2026Rating: Guggenheim · Buy → Buy
- Sep 10, 2026Rating: HSBC · Hold → Hold
- Oct 6, 2026Rating: Scotiabank · Sector Outperform → Sector Outperform
- Oct 8, 2026Rating: Cantor Fitzgerald · Neutral → Neutral
- Oct 9, 2026Rating: JP Morgan · Neutral → Neutral
- Nov 3, 2026Earnings: —; estimate 0.735; surprise —%
- Nov 6, 2026Dividend: 0.43
Signals (86)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
Newest 20 of 86.
Analyst view
Consensus: buy
Buy
Price target (mean) 29.26 -4.0% downside
Now 30.49
- Target (low)
- 25.00
- Target (mean)
- 29.26
- Target (high)
- 36.00
Ratings (0m) 28 9 buy · 17 hold · 2 sell
- Strong buy1
- Buy8
- Hold17
- Sell1
- Strong sell1
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.72803 | 0.56 – 0.83 | 0.87 | -16.3% | 15.88B | -4.7% | 19 |
| Next quarter | 0.70613 | 0.63 – 0.83 | 0.66 | +7.0% | 16.89B | -3.8% | 17 |
| Current year | 2.96 | 2.88 – 3.07 | 3.22 | -8.1% | 62.23B | -0.5% | 24 |
| Next year | 2.89 | 2.52 – 3.15 | 2.96 | -2.4% | 59.89B | -3.8% | 22 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 6, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Sep 10, 2026 | HSBC | Maintained | Hold | Hold |
| Aug 7, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 13, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 13, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 10, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Jul 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 6, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jul 6, 2026 | HSBC | Downgrade | Buy | Hold |
| Jun 10, 2026 | RBC Capital | Upgrade | Underperform | Sector Perform |
| Apr 29, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 20, 2026 | RBC Capital | Reiterated | Underperform | Underperform |
| Apr 16, 2026 | CICC | Initiated | — | Outperform |
| Apr 13, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 10, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 9, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| Mar 24, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 17, 2026 | HSBC | Maintained | Buy | Buy |
| Mar 2, 2026 | Argus Research | Upgrade | Hold | Buy |
| Feb 25, 2026 | RBC Capital | Initiated | — | Underperform |
| Feb 20, 2026 | Barclays | Initiated | — | Underweight |
| Feb 9, 2026 | Freedom Broker | Maintained | Buy | Buy |
| Feb 4, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jan 27, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Dec 17, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Dec 15, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Dec 12, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 24, 2025 | Guggenheim | Maintained | Buy | Buy |